Product information

Current status:

Approved

Current status date:

2023-09-26

Product name:

APO-APREMILAST TABLETS

Description:

STARTER PACK

DIN:

02541661 Electronic product monograph is not available

Company:

APOTEX INC
150 Signet Drive
Toronto
Ontario
Canada M9L 1T9

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

3

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

92:36.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

L04AA32 APREMILAST

Active ingredient group (AIG) number:^{See footnote5}

0356230001

Risk Management Plans ^{See footnote 7}

A Risk Management Plan (RMP) for this product was submitted.